Back to search
FDAFDA · Food and drugs·Recall number D-0253-2025

Lorazepam 0.5 mg per 0.25 mL Oral Syringe, Delivers: 0.25 mL, Oral Concentrate, Rx Only, Refrigerate, Mfg by: PAI, Pkg by: Safecor Health, LLC, Columbus, OH 43204, NDC: a) 00054353244, b) 00121077001, c) 65162068784.

Published March 12, 2025 · Recall initiated: February 17, 2025

Summary

FDA records drug Class II recall D-0253-2025, published March 12, 2025 and initiated February 17, 2025. Recalling firm: Safecor Health, LLC; Status: Ongoing; Reported quantity: 3465 Oral Syringes; Lot: Lot #s: a) 24210274, Exp 01/31/2025; 24401700, Exp 04/25/2025; b) 24251067, Exp 03/25/2025; 24421733, Exp 06/03/2025; c) 24261384, Exp 03/24/2025; 24370127, Exp 04/28/2025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Defective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Safecor Health, LLC
Distributor
Nationwide in the USA
Lot
Lot #s: a) 24210274, Exp 01/31/2025; 24401700, Exp 04/25/2025; b) 24251067, Exp 03/25/2025; 24421733, Exp 06/03/2025; c) 24261384, Exp 03/24/2025; 24370127, Exp 04/28/2025.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Lorazepam 0.5 mg per 0.25 mL Oral Syringe, Delivers: 0.25 mL, Oral Concentrate, Rx Only, Refrigerate, Mfg by: PAI, Pkg by: Safecor Health, LLC, Columbus, OH 43204, NDC: a) 00054353244, b) 00121077001, c) 65162068784. recalled?

Yes. FDA published recall D-0253-2025 on March 12, 2025. Reported hazard: Defective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes.

What should I do if I have this product?

Voluntary: Firm initiated · Letter